全文获取类型
收费全文 | 387篇 |
免费 | 47篇 |
专业分类
434篇 |
出版年
2021年 | 8篇 |
2020年 | 3篇 |
2019年 | 3篇 |
2017年 | 4篇 |
2016年 | 7篇 |
2015年 | 8篇 |
2014年 | 21篇 |
2013年 | 15篇 |
2012年 | 19篇 |
2011年 | 14篇 |
2010年 | 21篇 |
2009年 | 19篇 |
2008年 | 18篇 |
2007年 | 25篇 |
2006年 | 24篇 |
2005年 | 22篇 |
2004年 | 14篇 |
2003年 | 18篇 |
2002年 | 15篇 |
2001年 | 12篇 |
2000年 | 18篇 |
1999年 | 12篇 |
1998年 | 16篇 |
1997年 | 9篇 |
1996年 | 4篇 |
1994年 | 11篇 |
1993年 | 6篇 |
1992年 | 9篇 |
1991年 | 5篇 |
1990年 | 7篇 |
1989年 | 2篇 |
1988年 | 5篇 |
1986年 | 4篇 |
1985年 | 2篇 |
1982年 | 3篇 |
1977年 | 2篇 |
1976年 | 2篇 |
1975年 | 3篇 |
1973年 | 2篇 |
1970年 | 2篇 |
1967年 | 1篇 |
1965年 | 1篇 |
1962年 | 1篇 |
1955年 | 1篇 |
1952年 | 1篇 |
1948年 | 1篇 |
1947年 | 1篇 |
1887年 | 2篇 |
1885年 | 1篇 |
1883年 | 1篇 |
排序方式: 共有434条查询结果,搜索用时 15 毫秒
51.
52.
53.
beta4 integrin and epidermal growth factor coordinately regulate electric field-mediated directional migration via Rac1 下载免费PDF全文
Pullar CE Baier BS Kariya Y Russell AJ Horst BA Marinkovich MP Isseroff RR 《Molecular biology of the cell》2006,17(11):4925-4935
Endogenous DC electric fields (EF) are present during embryogenesis and are generated in vivo upon wounding, providing guidance cues for directional cell migration (galvanotaxis) required in these processes. To understand the role of beta (beta)4 integrin in directional migration, the migratory paths of either primary human keratinocytes (NHK), beta4 integrin-null human keratinocytes (beta4-), or those in which beta4 integrin was reexpressed (beta4+), were tracked during exposure to EFs of physiological magnitude (100 mV/mm). Although the expression of beta4 integrin had no effect on the rate of cell movement, it was essential for directional (cathodal) migration in the absence of epidermal growth factor (EGF). The addition of EGF potentiated the directional response, suggesting that at least two distinct but synergistic signaling pathways coordinate galvanotaxis. Expression of either a ligand binding-defective beta4 (beta4+AD) or beta4 with a truncated cytoplasmic tail (beta4+CT) resulted in loss of directionality in the absence of EGF, whereas inhibition of Rac1 blinded the cells to the EF even in the presence of EGF. In summary, both the beta4 integrin ligand-binding and cytoplasmic domains together with EGF were required for the synergistic activation of a Rac-dependent signaling pathway that was essential for keratinocyte directional migration in response to a galvanotactic stimulus. 相似文献
54.
Lutz-Nicoladoni C Wallner S Stoitzner P Pircher M Gruber T Wolf AM Gastl G Penninger JM Baier G Wolf D 《Immunology and cell biology》2012,90(1):130-134
The success of cancer immunotherapy is limited by potent endogenous immune-evasion mechanisms, which are at least in part mediated by transforming growth factor-β (TGF-β). The E3 ubiquitin ligase Cbl-b is a key regulator of T cell activation and is established to regulate TGF-β sensitivity. cblb-deficient animals reject tumors via CD8(+) T cells, which make Cbl-b an ideal target for improvement of adoptive T-cell transfer (ATC) therapy. In this study, we show that cblb-deficient CD8(+) T cells are hyper-responsive to T-cell receptor (TCR)/CD28-stimulation and are in part protected against the negative cues induced by TGF-β in vitro. Notably, adoptive transfer of polyclonal, non-TCR transgenic cblb-deficient CD8(+) T cells is not sufficient to reject B16-ova or EG7 tumors in vivo. Thus, cblb-deficient ATC requires proper in vivo re-activation by a dendritic cell (DC) vaccine. In strict contrast to ATC monotherapy, this approach delayed tumor outgrowth and significantly increased survival rates, which is paralleled by increased CD8(+) T-cells infiltration to the tumor site and enrichment of ova-specific and interferon-γ (IFN-γ)-secreting CD8(+) T cell in the draining lymph node (LN). Moreover, CD8(+) T cells from cblb-deficient mice vaccinated with the DC vaccine show increased cytolytic activity in vivo. In summary, our data using cblb-deficient polyclonal, non-TCR-transgenic adoptively transferred CD8(+) T cells into immuno-competent non-lymphodepleted recipients suggest that targeting Cbl-b might serve as a novel 'adjuvant approach', suitable to augment the effectiveness of established anti-cancer immunotherapies. 相似文献
55.
56.
B Bauer N Krumb?ck F Fresser F Hochholdinger M Spitaler A Simm F Uberall B Schraven G Baier 《The Journal of biological chemistry》2001,276(34):31627-31634
57.
58.
59.
60.